HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1.

Juan BerenguerJosé Luis CallejaMaría Luisa MontesÁngela GilAna MorenoRafael BañaresTeresa Aldámiz-EchevarríaAgustín AlbillosMaría Jesús TéllezAntonio OlveiraLourdes DomínguezInmaculada FernándezJavier García-SamaniegoBenjamín A PoloBeatriz ÁlvarezPablo RyanJosé BarrioMaría J DevesaLaura BenítezIgnacio SantosLuisa García BueyJosé SanzElvira PovesJuan E LosaConrado Fernández-RodríguezInmaculada JarrínMaría J CalvoJuan González-García

Published in: Open forum infectious diseases (2019)

The results of this large prospective study analyzing outcomes for LDV/SOF against HCV G1 in treatment-naïve noncirrhotic patients suggest that HIV infection is a predictor of treatment failure in patients with chronic hepatitis C.

Keyphrases

hepatitis c virus
antiretroviral therapy
type diabetes
newly diagnosed
metabolic syndrome
hiv aids
south africa
weight loss